Dr Pascale Tomasini
- Spécialité
- Oncologue médical, expert poumon
- Hôpital
- AP-HM Hôpital Nord (Marseille)
- Derniers articles
-
- Durability of Response With Selpercatinib in Patients With RET-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001. (20 sept. 2024)
- Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR-Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial. (1 sept. 2024)
- Impact of preexisting interstitial lung disease on outcomes of lung cancer surgery: A monocentric retrospective study. (30 juil. 2024)
- The landscape of cancer-associated transcript fusions in adult brain tumors: a longitudinal assessment in 140 patients with cerebral gliomas and brain metastases. (17 juil. 2024)
- Safety and Patient-Reported outcomes of atezolizumab plus chemotherapy with or without bevacizumab in stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies (GFPC 06-2018 study). (1 juil. 2024)